229
HemoSphere Advanced Monitor G Guidance and Manufacturer’s Declaration
• EN 301 489-1 V1.6.1: (2005-09)
Electromagnetic compatibility and Radio Spectrum Matters (ERM); ElectroMagnetic Compatibility
(EMC) standard for radio equipment and services; Part 1: Common technical requirements
• EN 301 489-17 V1.2.1 (2002-08)
Electromagnetic compatibility and Radio spectrum Matters (ERM); ElectroMagnetic Compatibility
(EMC) standard for radio equipment and services; Part 17: Specific conditions for 2,4 GHz
wideband transmission systems and 5 GHz high performance RLAN equipment
• EN 301 893 V1.5.1 (2008-12)
Electromagnetic compatibility and Radio spectrum Matters (ERM); Broadband Radio Access
Networks (BRAN); Specific conditions for 5 GHz high performance RLAN equipment
• EU 2002/95/EC (RoHS)
Declaration of Compliance – EU Directive 2003/95/EC; Reduction of Hazardous Substances
(RoHS)
This device is a 2.4 GHz wideband transmission system (transceiver), intended for use in all EU member
states and EFTA countries, except in France and Italy where restrictive use applies.
In Italy the end-user should apply for a license at the national spectrum authorities in order to obtain
authorization to use the device for setting up outdoor radio links and/or for supplying public access to
telecommunications and/or network services.
This device may not be used for setting up outdoor radio links in France and in some areas the RF output
power may be limited to 10 mW EIRP in the frequency range of 2454 – 2483.5 MHz. For detailed
information the end-user should contact the national spectrum authority in France.
Hereby, Edwards Lifesciences, declares that this monitor is in compliance with the essential requirements
and other relevant provisions of Directive 1999/5/EC.
Status = Released Printed Date: 2018-01-16 Released Date: 2017-09-14
To Next Page
Loading...